Menu
Recruiting NCT07315932

Perception of Hormonal Replacement Therapy Among Patients Aged 11 to 17 Years

Observational Female Hypogonadism

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
This is an observational study: the protocol does not assign a study treatment.
Who it may be relevant to
Registry conditions: Female Hypogonadism. Basic parameters: 11 years — 18 years · Female.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
France
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Current Knowledge and Perceptions of Hormone Replacement Therapy Among Patients Aged 11 to 18 Years, and Their Parents, Treated for Hypogonadism at the Strasbourg University Hospital

Overview

To establish a current knowledge and perception of patients and their parents regarding HRT in order to assess the needs that can promote understanding and adherence to treatment by implementing therapeutic education workshops

Primary outcome measures

  • Assessment of patients' knowledge about the composition of hormonal treatment for female hypogonadism [Time frame: Up to 7 months]
  • Assessment of patients' knowledge regarding the effects of hormonal treatment for female hypogonadism [Time frame: Up to 7 months]

Eligibility criteria

Inclusion criteria

  • Female patients aged 11 to 18 years
  • Treated at the University Hospital of Strasbourg for central or peripheral hypogonadism with the initiation of hormone replacement therapy

Exclusion criteria

\- Inability to provide the subject with clear information (difficulties understanding the subject, language barrier, illiteracy, etc.)

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Study design

Observational model
Case-only

Study locations

France · 1 center
  • Service de Gynécologie et obstétrique - CHU de Strasbourg - France — Strasbourg

Identifiers

NCT: NCT07315932 · 9620

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗